Method for treating ocular cancer

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 8470785
APP PUB NO 20120115880A1
SERIAL NO

13246202

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

Compositions and methods for treating ocular cancer are provided. The composition is a subconjunctival formulation of nutlin-3 and its analogs. The composition provides for methods of treating ocular cancer, including retinoblastoma. The formulation has high penetration into ocular tissue with low toxicity.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
UNIVERSITEIT GENTSINT-PIETERSNIEUWSTRAAT 25 GENT 9000
VIB VZWRIJVISSCHESTRAAT 120 9052 GENT BELGIUM

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Dyer, Michael A Memphis, US 3 24
Guy, R Kip Memphis, US 3 20
Jochemsen, Aart Gerrit Leiden, NL 3 24
Marine, Jean-Christophe Erbisoeul, BE 13 65
Zhu, Fangyi Memphis, US 3 17

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
11.5 Year Payment $7400.00 $3700.00 $1850.00 Dec 25, 2024
Fee Large entity fee small entity fee micro entity fee
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00